Vertex Pharmaceuticals Incorporated
Crystalline forms and compositions of CFTR modulators

Last updated:

Abstract:

Crystalline Forms of Compound I: ##STR00001## and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

Status:
Grant
Type:

Utility

Filling date:

19 Oct 2018

Issue date:

19 May 2020